Helicobacter pylori lipopolysaccharide (H. pylori LPS)

Helicobacter pylori lipopolysaccharide is a large, complex glycolipid present in the outer membrane of H. pylori, a Gram-negative bacterium that colonizes the human stomach[1]. Its unique structural features include variation in its lipid A region (which lowers its immunostimulatory activity), presence of Lewis blood group antigen mimics on its O-antigen side chains (which help H. pylori escape immune detection), and a variable core oligosaccharide[1][3][5][6]. The molecule modulates host immunity by suppressing Toll-like receptor signaling pathways and cytokine production, promotes colonization through adhesion to host tissues, and contributes to chronic infection and persistent inflammation by blunting normal immune responses[2][6][7]. It is not directly targeted by approved drugs, but its antigenic components are of interest for research into diagnostics, vaccine development, and understanding H. pylori-associated diseases such as gastritis, peptic ulcers, and potentially autoimmune responses[4][6].

Other names

H. pylori LPSHelicobacter pylori endotoxinHelicobacter pylori O antigen (refers to a subdomain)Helicobacter pylori lipid A (refers to a subdomain)

Not directly targeted by drugs; however, hypothetical mechanisms include: - Antibody-mediated neutralization of LPS antigenic sites - Inhibition of its biosynthesis pathway - Enhancement of immune recognition by modifying or blocking immune-evasive properties